CONMED ROE 2010-2024 | CNMD

Current and historical return on equity (ROE) values for CONMED (CNMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
CONMED ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.13B 20.54%
2024-06-30 $0.10B $0.88B 11.76%
2024-03-31 $0.08B $0.86B 10.17%
2023-12-31 $0.07B $0.83B 8.22%
2023-09-30 $0.06B $0.80B 7.68%
2023-06-30 $0.09B $0.78B 11.89%
2023-03-31 $-0.09B $0.75B -12.89%
2022-12-31 $-0.08B $0.75B -10.94%
2022-09-30 $-0.08B $0.72B -11.20%
2022-06-30 $-0.11B $0.67B -15.18%
2022-03-31 $0.07B $0.79B 8.72%
2021-12-31 $0.06B $0.79B 8.24%
2021-09-30 $0.06B $0.76B 8.45%
2021-06-30 $0.05B $0.74B 7.55%
2021-03-31 $0.01B $0.73B 2.01%
2020-12-31 $0.01B $0.71B 1.44%
2020-09-30 $0.00B $0.68B 0.14%
2020-06-30 $0.00B $0.68B 0.14%
2020-03-31 $0.03B $0.70B 4.84%
2019-12-31 $0.03B $0.71B 4.14%
2019-09-30 $0.03B $0.70B 4.36%
2019-06-30 $0.03B $0.70B 4.29%
2019-03-31 $0.03B $0.69B 4.82%
2018-12-31 $0.04B $0.66B 6.45%
2018-09-30 $0.07B $0.65B 11.34%
2018-06-30 $0.07B $0.65B 11.78%
2018-03-31 $0.07B $0.64B 11.61%
2017-12-31 $0.06B $0.63B 9.25%
2017-09-30 $0.02B $0.59B 2.58%
2017-06-30 $0.02B $0.58B 2.58%
2017-03-31 $0.01B $0.58B 2.07%
2016-12-31 $0.02B $0.58B 2.58%
2016-09-30 $0.02B $0.58B 2.75%
2016-06-30 $0.02B $0.58B 3.10%
2016-03-31 $0.02B $0.58B 3.79%
2015-12-31 $0.03B $0.59B 5.19%
2015-09-30 $0.03B $0.58B 5.71%
2015-06-30 $0.03B $0.58B 4.47%
2015-03-31 $0.03B $0.57B 4.94%
2014-12-31 $0.03B $0.58B 5.40%
2014-09-30 $0.03B $0.59B 5.18%
2014-06-30 $0.04B $0.60B 5.85%
2014-03-31 $0.04B $0.60B 5.89%
2013-12-31 $0.04B $0.61B 6.05%
2013-09-30 $0.04B $0.59B 6.21%
2013-06-30 $0.04B $0.59B 6.69%
2013-03-31 $0.04B $0.60B 6.67%
2012-12-31 $0.04B $0.61B 6.70%
2012-09-30 $0.00B $0.60B 0.68%
2012-06-30 $0.00B $0.59B 0.51%
2012-03-31 $0.00B $0.59B 0.34%
2011-12-31 $0.00B $0.57B 0.17%
2011-09-30 $0.03B $0.61B 5.47%
2011-06-30 $0.03B $0.62B 5.70%
2011-03-31 $0.03B $0.60B 5.46%
2010-12-31 $0.03B $0.59B 5.15%
2010-09-30 $0.03B $0.58B 4.83%
2010-06-30 $0.02B $0.58B 3.46%
2010-03-31 $0.01B $0.58B 2.44%
2009-12-31 $0.01B $0.58B 1.94%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.337B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
Merit Medical Systems (MMSI) United States $5.972B 30.50
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95